Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma

Cancer Science

Volumn 99, Issue 8, 2008, Pages 1564-1569

  Nomura, Yuko ^a,b   Yoshida, Shiro ^a   Karube, Kennosuke ^a   Takeshita, Morishige ^b   Hirose, Shinichi ^b   Nakamura, Shigeo ^c   Yoshino, Tadashi ^d   Kikuchi, Masahiro ^e   Ohshima, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e Murakami Karindoh Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; KI 67 ANTIGEN; METHOTREXATE; PREDNISOLONE; PROTEIN BCL 2; VINCRISTINE;

AGED; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SHORT COURSE THERAPY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BURKITT LYMPHOMA; CASPASE 3; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 49749116792     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00851.x     Document Type: Article

References (37)

1. Wyllie AH, Kerr JF, Currie AR. Cell death. the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
2. Arends MJ, Wyllie AH. Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223-54.
3. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992; 10: 267-93.
4. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999; 6: 1028-42.
5. Konstantinidou AE, Givalos N, Gakiopoulou H et al. Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas. Apoptosis 2007; 12: 695-705.
6. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000; 157: 1415-30.
7. Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: Immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 2002; 50: 449-54.
8. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999; 6: 99-104.
9. Woo M, Hakem R, Soengas MS et al. Essential contribution of caspase 3/ CPP32 to apoptosis and its associated nuclear changes. Genes Dev 1998; 12: 806-19.
10. Diebold JJE, Raphael M, Warnke RA. Burkitt lymphoma. In: Jaffe ES HN, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001.
11. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
12. Chuang SS, Ye H, Du MQ et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. Am J Clin Pathol 2007; 128: 558-64.
13. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood 2004; 104: 3009-20.
14. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol 2000; 18: 3707-21.
15. Pelengaris S, Khan M, Evan G. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2002; 2: 764-76.
16. Braziel RM, Arber DA, Slovak ML et al. The Burkitt-like lymphomas: A Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood 2001; 97: 3713-20.
17. Nakamura N, Nakamine H, Tamaru J et al. The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-myc rearrangement. Mod Pathol 2002; 15: 771-6.
18. Nomura Y, Karube K, Suzuki R et al. High-grade mature B-cell lymphoma with Burkitt-like morphology: Results of a clinicopathologic study of 72 Japanese patients. Cancer Sci 2008; 99: 246-52.
19. Ohshima K, Kawasaki C, Muta H et al. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology 2001; 39: 156-62.
20. Nomura Y, Sugita Y, Yoshida S et al. Estimation of apoptosis and cell proliferation in histiocytic necrotizing lymphadenitis using immunohistochemical double staining. Pathol Int 2008; 58: 98-103.
21. Li JY, Gaillard F, Moreau A et al. Detection of translocation t(11;14) (q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 1999; 154: 1449-52.
22. Kodama T, Ohshima K, Nomura K et al. Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma. Histopathology 2005; 47: 467-78.
23. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993; 22: 355-60.
24. Chrysomali E, Nikitakis NG, Tosios K, Sauk JJ, Papanicolaou SI. Immunohistochemical evaluation of cell proliferation antigen Ki-67 and apoptosis-related proteins Bcl-2 and caspase-3 in oral granular cell tumor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 566-72.
25. Hakimelahi S, Parker HR, Gilchrist AJ et al. Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J Biol Chem 2000; 275: 10.905-11.
26. Truffinet V, Pinaud E, Cogne N et al. The 3′ IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J Immunol 2007; 179: 6033-42.
27. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220-35.
28. Zhang X, Zhang Q, Zhang Z, Na Y, Guo Y. Apoptosis profiles in benign prostatic hyperplasia: Close associations of cell kinetics with percent area density of histologic composition. Urology 2006; 68: 905-10.
29. Kondo S, Senoo-Matsuda N, Hiromi Y, Miura M. DRONC coordinates cell death and compensatory proliferation. Mol Cell Biol 2006; 26: 7258-68.
30. Huh JR, Guo M, Hay BA. Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr Biol 2004; 14: 1262-6.
31. Vital-Reyes V, Rodriguez-Burford C, Chhieng DC, Alvarado-Cabrero I, Reyes-Fuentes A, Grizzle WE. Ovarian expression of markers associated with proliferation or apoptosis in women with diminished ovarian reserve. Fertil Steril 2006; 86: 176-85.
32. Ryoo HD, Gorenc T, Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 2004; 7: 491-501.
33. Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992; 11: 121-39.
34. Daniels I, Abulayha AM, Thomson BJ, Haynes AP. Caspase-independent killing of Burkitt lymphoma cell lines by rituximab. Apoptosis 2006; 11: 1013-23.
35. Cairo MS, Sposto R, Perkins SL et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: A review of the Children's Cancer Group experience. Br J Haematol 2003; 120: 660-70.
36. Todeschini G, Tecchio C, Degani D et al. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: No differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol. Ann Oncol 1997; 8 (Suppl 1): 77-81.
37. Adde M, Shad A, Venzon D et al. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Semin Oncol 1998; 25: 33-9; discussion 45-8.